News Daily News Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival L.A. McKeown July 20, 2023
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News EuroPCR 2023 Many ACS Patients With Occlusions Are Falling Through the Cracks Todd Neale May 19, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2023 Shelley Wood March 01, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News How Lp(a) Levels Compare With LDL-C in FH: Some Surprises Michael O'Riordan November 17, 2022
News Daily News New Risk Models Superior to Pretest Probability at Predicting CAD Yael L. Maxwell November 15, 2022
News Daily News SCAD in Men: Canadian Study Sheds Light on Rare Condition Caitlin E. Cox October 25, 2022
News Conference News TCT 2022 PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI Shelley Wood September 22, 2022
News Daily News CV Risk Factors, Disease Projected to Explode in Coming Decades L.A. McKeown August 01, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains Michael O'Riordan May 03, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Daily News Homozygous FH Diagnosis Often Comes Late, With Lackluster Care Michael O'Riordan February 10, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022